Funding sources Editorial support was provided by Succinct Healthcare Communications and funded by a grant provided by Roche Products Ltd.
Cutaneous adverse events associated with vemurafenib in patients with metastatic melanoma: practical advice on diagnosis, prevention and management of the main treatment-related skin toxicities
Article first published online: 29 OCT 2012
© 2012 The Authors. BJD © 2012 British Association of Dermatologists
British Journal of Dermatology
Volume 167, Issue 5, pages 987–994, November 2012
How to Cite
Sinha, R., Edmonds, K., Newton-Bishop, J.A., Gore, M.E., Larkin, J. and Fearfield, L. (2012), Cutaneous adverse events associated with vemurafenib in patients with metastatic melanoma: practical advice on diagnosis, prevention and management of the main treatment-related skin toxicities. British Journal of Dermatology, 167: 987–994. doi: 10.1111/bjd.12010
Conflicts of interest R.S. has none to declare. K.E. has acted as an advisor to Roche on the practical use of vemurafenib. J.A.N.-B. has acted as an advisor to Roche on cutaneous toxicities associated with vemurafenib and has received honoraria to speak at a Roche-sponsored meeting; she declares no conflict of interest. M.G. has received honoraria to speak at a Roche-sponsored meeting. J.L. has received honoraria from Bristol-Myers Squibb, GlaxoSmithKline, Roche and Novartis and has received research funding from Novartis. L.F. has received honoraria to speak at a Roche-sponsored meeting; she declares no conflict of interest.
- Issue published online: 29 OCT 2012
- Article first published online: 29 OCT 2012
- Accepted manuscript online: 22 AUG 2012 09:35AM EST
- Accepted for publication 11 August 2012
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.